Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Rodriguez Cruz PM"" wg kryterium: Autor


Wyświetlanie 1-2 z 2
Tytuł:
Myasthenic syndromes due to defects in COL13A1 and in the N-linked glycosylation pathway.
Autorzy:
Beeson D; Neurosciences Group, Nuffield Department of Clinical Neuroscience, Weatherall Institute of Molecular Medicine, The John Radcliffe, Oxford, UK.
Cossins J; Neurosciences Group, Nuffield Department of Clinical Neuroscience, Weatherall Institute of Molecular Medicine, The John Radcliffe, Oxford, UK.
Rodriguez Cruz PM; Neurosciences Group, Nuffield Department of Clinical Neuroscience, Weatherall Institute of Molecular Medicine, The John Radcliffe, Oxford, UK.
Maxwell S; Neurosciences Group, Nuffield Department of Clinical Neuroscience, Weatherall Institute of Molecular Medicine, The John Radcliffe, Oxford, UK.
Liu WW; Neurosciences Group, Nuffield Department of Clinical Neuroscience, Weatherall Institute of Molecular Medicine, The John Radcliffe, Oxford, UK.
Palace J; Nuffield Department of Clinical Neuroscience, Level 3 The West Wing, The John Radcliffe, Oxford, UK.
Pokaż więcej
Źródło:
Annals of the New York Academy of Sciences [Ann N Y Acad Sci] 2018 Feb; Vol. 1413 (1), pp. 163-169. Date of Electronic Publication: 2018 Jan 24.
Typ publikacji:
Journal Article
MeSH Terms:
Collagen Type XIII/*genetics
Myasthenic Syndromes, Congenital/*genetics
Myasthenic Syndromes, Congenital/*immunology
Neuromuscular Junction/*immunology
Synaptic Transmission/*physiology
Collagen Type XIII/metabolism ; Extracellular Matrix Proteins/genetics ; Glycosylation ; Humans
Czasopismo naukowe
Tytuł:
Serological and experimental studies in different forms of myasthenia gravis.
Autorzy:
Vincent A; Neuroimmunology Group, Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK.
Huda S; Neuroimmunology Group, Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK.
Cao M; Neuroimmunology Group, Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK.
Cetin H; Neuroimmunology Group, Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK.
Koneczny I; Neuroimmunology Group, Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK.
Rodriguez Cruz PM; Neuroimmunology Group, Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK.
Jacobson L; Neuroimmunology Group, Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK.
Viegas S; Neuroimmunology Group, Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK.
Jacob S; Neuroimmunology Group, Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK.
Woodhall M; Neuroimmunology Group, Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK.
Nagaishi A; Neuroimmunology Group, Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK.
Maniaol A; Neuroimmunology Group, Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK.
Damato V; Neuroimmunology Group, Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK.
Leite MI; Neuroimmunology Group, Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK.
Cossins J; Neuroimmunology Group, Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK.
Webster R; Neuroimmunology Group, Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK.
Palace J; Neuroimmunology Group, Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK.
Beeson D; Neuroimmunology Group, Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK.
Pokaż więcej
Źródło:
Annals of the New York Academy of Sciences [Ann N Y Acad Sci] 2018 Feb; Vol. 1413 (1), pp. 143-153. Date of Electronic Publication: 2018 Jan 29.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Autoantibodies/*immunology
Myasthenia Gravis/*immunology
Receptor Protein-Tyrosine Kinases/*immunology
Receptors, Cholinergic/*immunology
Agrin/immunology ; Humans ; Immunoglobulin G/immunology ; Kv1.4 Potassium Channel/immunology ; LDL-Receptor Related Proteins/immunology ; Myasthenia Gravis/classification
Czasopismo naukowe
    Wyświetlanie 1-2 z 2

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies